Amylin Pharmaceuticals, Inc.
9360 Towne Centre Drive
San Diego
California
92121
United States
Tel: 858-552-2200
Fax: 858-552-2212
Website: http://www.amylin.com/
Email: IR@amylin.com
370 articles about Amylin Pharmaceuticals, Inc.
-
Amylin Pharmaceuticals, Inc. to Present at the Bank of America 2011 Healthcare Conference
5/6/2011
-
Amylin Pharmaceuticals, Inc. to Present at the Deutsche Bank 36th Annual Healthcare Conference
4/28/2011
-
Amylin Pharmaceuticals, Inc. Reports First Quarter Financial Results
4/18/2011
-
Amylin Pharmaceuticals, Inc. to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy
4/15/2011
-
Amylin Pharmaceuticals, Inc. to Webcast First Quarter Results
4/12/2011
-
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Co. Ltd. Voluntarily Suspend Clinical Activities in Obesity Trial
3/17/2011
-
Amylin Pharmaceuticals, Inc. Exenatide Once Monthly Showed Positive Results in Phase 2 Study
3/10/2011
-
Amylin Pharmaceuticals, Inc. to Present at the Barclays Capital 2011 Global Healthcare Conference
3/9/2011
-
Amylin Pharmaceuticals, Inc. to Present at the 2011 ISI Annual Conference
2/9/2011
-
Amylin Pharmaceuticals, Inc. 4th-Quarter Loss Narrows, Byetta Sales Drop
1/27/2011
-
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company Seek Expanded Use of BYETTA(R) Along with Basal Insulin
12/27/2010
-
Amylin Pharmaceuticals, Inc. Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy
12/20/2010
-
Amylin Pharmaceuticals, Inc., Eli Lilly and Company Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated with BYETTA(R) Compared to Insulin, Thiazolidinediones, Sulfonylureas, Metformin and Januvia(
11/17/2010
-
Amylin Pharmaceuticals, Inc. to Present at the Citi 7th Annual US Small/Mid Cap Conference
11/10/2010
-
Amylin Pharmaceuticals, Inc. to Present at the 2010 Credit Suisse Healthcare Conference
11/5/2010
-
Amylin Pharmaceuticals, Inc. Reports Third Quarter Financial Results
11/5/2010
-
Amylin Pharmaceuticals, Inc. to Webcast Third Quarter Results
10/29/2010
-
Eli Lilly and Company's Diabetes Setbacks May Spur Shopping Spree Beyond Amylin Pharmaceuticals, Inc.
10/25/2010
-
Amylin Pharmaceuticals, Inc. Announces Third Quarter Product Revenues; Quarterly Update Conference Call Canceled
10/20/2010
-
FDA Approval Of Amylin Pharmaceuticals, Inc., Eli Lilly and Company, and Alkermes's Bydureon Diabetes Medicine Expected but Still Uncertain
10/18/2010